前列腺癌背景下的前列腺动脉栓塞：综述和观点。

IF 2.5 4区医学 Q3 ONCOLOGY

Cancer Control Pub Date : 2025-01-01 DOI:10.1177/10732748251317691

Nainesh Parikh, Kosj Yamoah, Peter Johnstone, Javier Torres-Roca, Julio Pow-Sang, Daniel Fernandez, Anupam Rishi, G Daniel Grass

{"title":"前列腺癌背景下的前列腺动脉栓塞：综述和观点。","authors":"Nainesh Parikh, Kosj Yamoah, Peter Johnstone, Javier Torres-Roca, Julio Pow-Sang, Daniel Fernandez, Anupam Rishi, G Daniel Grass","doi":"10.1177/10732748251317691","DOIUrl":null,"url":null,"abstract":"Prostate Artery Embolization (PAE) is a novel minimally invasive angiographic technique that has been used effectively to treat men with lower urinary tract symptoms (LUTS) from benign prostatic hyperplasia (BPH). However, applications of PAE for men with prostate cancer have been minimally studied. This review serves as an update on the status of PAE in men with prostate cancer, as well as a discussion of emerging indications.","PeriodicalId":49093,"journal":{"name":"Cancer Control","volume":"32 ","pages":"10732748251317691"},"PeriodicalIF":2.5000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11775958/pdf/","citationCount":"0","resultStr":"{\"title\":\"Prostate Artery Embolization in the Setting of Prostate Cancer: Review and Opinion.\",\"authors\":\"Nainesh Parikh, Kosj Yamoah, Peter Johnstone, Javier Torres-Roca, Julio Pow-Sang, Daniel Fernandez, Anupam Rishi, G Daniel Grass\",\"doi\":\"10.1177/10732748251317691\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Prostate Artery Embolization (PAE) is a novel minimally invasive angiographic technique that has been used effectively to treat men with lower urinary tract symptoms (LUTS) from benign prostatic hyperplasia (BPH). However, applications of PAE for men with prostate cancer have been minimally studied. This review serves as an update on the status of PAE in men with prostate cancer, as well as a discussion of emerging indications.\",\"PeriodicalId\":49093,\"journal\":{\"name\":\"Cancer Control\",\"volume\":\"32 \",\"pages\":\"10732748251317691\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11775958/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Control\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/10732748251317691\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Control","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10732748251317691","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

前列腺动脉栓塞（PAE）是一种新型的微创血管造影技术，已被有效地用于治疗男性良性前列腺增生（BPH）引起的下尿路症状（LUTS）。然而，PAE在前列腺癌患者中的应用研究很少。本综述提供了前列腺癌患者PAE现状的最新进展，并对新出现的适应症进行了讨论。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Prostate Artery Embolization in the Setting of Prostate Cancer: Review and Opinion.

Prostate Artery Embolization (PAE) is a novel minimally invasive angiographic technique that has been used effectively to treat men with lower urinary tract symptoms (LUTS) from benign prostatic hyperplasia (BPH). However, applications of PAE for men with prostate cancer have been minimally studied. This review serves as an update on the status of PAE in men with prostate cancer, as well as a discussion of emerging indications.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cancer Control ONCOLOGY-

CiteScore

3.80

自引率

0.00%

发文量

148

审稿时长

>12 weeks

期刊介绍： Cancer Control is a JCR-ranked, peer-reviewed open access journal whose mission is to advance the prevention, detection, diagnosis, treatment, and palliative care of cancer by enabling researchers, doctors, policymakers, and other healthcare professionals to freely share research along the cancer control continuum. Our vision is a world where gold-standard cancer care is the norm, not the exception.